Publication: Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study
Open/View Files
Date
2017
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Oxford University Press
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Parker, Robert A., Dustin J. Rabideau, Paul E. Sax, Camlin Tierney, Eric S. Daar, Ann C. Collier, Elena Losina, and Kenneth A. Freedberg. 2017. “Impact of Medication Adherence on Virologic Failure in A5202: A Randomized, Partially Blinded, Phase 3B Study.” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 64 (11): 1612-1614. doi:10.1093/cid/cix176. http://dx.doi.org/10.1093/cid/cix176.
Research Data
Abstract
Abstract In AIDS Clinical Trials Group A5202, participants who reported missing their medication within the past month or not providing adherence reports at both 8 and 24 weeks had 5 times the hazard of virological failure compared to more adherent participants. Adherence interventions should focus on such patients.
Description
Other Available Sources
Keywords
HIV, missing medication, self-report, adherence, virologic failure.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service